Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid Retention

per Masuda, Takahiro, Murakami, Takuya, Igarashi, Yusuke, Okabe, Kyochika, Kobayashi, Takahisa, Takeda, Shin-ichi, Saito, Takako, Sekiguchi, Chuji, Miyazawa, Yasuharu, Akimoto, Tetsu, Saito, Osamu, Muto, Shigeaki, Nagata, Daisuke
Publicat a Intern Med (2016)

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease

per Kohara, Marina, Masuda, Takahiro, Shiizaki, Kazuhiro, Akimoto, Tetsu, Watanabe, Yuko, Honma, Sumiko, Sekiguchi, Chuji, Miyazawa, Yasuharu, Kusano, Eiji, Kanda, Yoshinobu, Asano, Yasushi, Kuro-o, Makoto, Nagata, Daisuke
Publicat a PLoS One (2017)

The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease

per Ohara, Ken, Masuda, Takahiro, Morinari, Masato, Okada, Mari, Miki, Atsushi, Nakagawa, Saki, Murakami, Takuya, Oka, Kentaro, Asakura, Maki, Miyazawa, Yasuharu, Maeshima, Akito, Akimoto, Tetsu, Saito, Osamu, Nagata, Daisuke
Publicat a Diabetol Metab Syndr (2020)